This Is MS Multiple Sclerosis Community: Knowledge & Support

Rituximab (rituxan) is in Phase ii trials (Biogen is the drugs company behind rituxan).

The following research paper suggests it has benefits - it affects B cells (rather than the usual T cells)

Bromley

http://www.msif.org/en/research/researc ... tabil.html

http://c.moreover.com/click/here.pl?j403390149&w=464753

Antisense Therapeutics were trialling an oral drug which targeted the same protein as Tysabri. The company stopped the trial following the Tysabri fiasco. The company has applied to restart the trial (may need to add to Dignan's list of approval given).


http://www.antisense.com.au/dl/415.pdf

New NeuroVax Data from the European MS Meeting


http://biz.yahoo.com/bw/051003/35350.html?.v=1



Dunmann.

http://biz.yahoo.com/bw/051003/35233.html?.v=1

http://c.moreover.com/click/here.pl?j399628250&w=464753


And another article which also refers to Mylinax (sp?). Still looking at 2008 or 2009 before an oral therapy is available.

http://c.moreover.com/click/here.pl?j399635862&w=464753

I have no idea what Padma28 is but it seems to have some benefit for chronic progressive ms sufferers.


http://www.ever.ch/padma28ms.htm


PS I found some more information - it's a Tibetan medicine.

<shortened url>

It seems to consist of a vast range of ingredients - as our nutrition expert Melody might translate for us.

<shortened url>

<shortened url>

<shortened url>